Prevention and Management of Clostridium Difficile Infection (CDI): The Latest Game Changer to Clinical Practice

Course overview

Clostridium difficile infection (CDI) accounts for nearly a half of a million cases annually. Recent guideline updates have occurred leading to changes in guideline preferred regimens for the treatment of CDI. Pharmacists should be aware of these guideline updates. This activity will review some of the more significant changes, identify primary and secondary prophylactic strategies for prevention of CDI, and explore the role of new and emerging therapies.